Establishment Labs opened lower at $70.47, compared with its previous close of $70.69. In the last trading session, the stock traded between $67.73 and $70.78. It showed a downward intraday trend.
Return calculator
Time Period
An investment of $100 made 5 years ago in Establishment Labs is now worth
$ 98.84
Resulting in a loss of
$ 1.16 (1.16%)
Invest with $1
Note: Past profits do not guarantee future returns.
Analyst Overview
Rating from 6 Analysts
Buy
100%
Hold
0%
Sell
0%
Markets Today
Today's Change
$-2.18 (-3.08%)
Day High
$70.78
Day Low
$67.73
Day Open
$70.47
Prev Close
$70.69
Volume
2,68,963
1W Return
2.41%
1M Return
11.45%
3M Return
-7.81%
6M Return
-4.18%
1Y Return
0.09%
Fundamentals
Market Cap ($ Mn)
2,043
PE Ratio
-
PB Ratio
97.43
PEG Ratio
-
ROE
-165.45%
ROCE
-12.44%
EPS (TTM)
$-0.39
Investment Returns
1 Week
2.41%
1 Month
11.45%
3 Months
-7.81%
6 Months
-4.18%
9 Months
-5.79%
Financials
Quarterly
All values in $ Mn
41.4
Mar 25
51.3
Jun 25
53.8
Sep 25
64.6
Dec 25
59.9
Mar 26
67.5
Jun 26
Updates
30Oct
BTIG maintains Buy on Establishment Labs, cuts price target to $93
BTIG analyst Sam Eiber maintains a Buy rating on Establishment Labs Holdings. Price target lowered from $103 to $93. Rating remains unchanged despite the target cut.
14 days ago
6Oct
Establishment Labs Q2 revenue up 31.7% to $67.5 million
Total revenue rose 31.7% YoY to $67.5 million. US revenue surged 140.9% to $24.7 million, now 36.6% of total sales. Adjusted EBITDA turned positive at $3.7 million vs loss of $8.5 million last year. Full-year revenue guidance raised to $269-$271 million.
1mo ago
21Sep
Establishment Labs unveils new breast tissue preservation data and product extensions
Establishment Labs presented new clinical data on breast tissue preservation at the 11th WSEI in Istanbul. The company announced new sizes and tools for its Mia and Preservé minimally invasive products. Over 1,000 surgeons from 57 countries attended the symposium featuring 127 scientific sessions. CEO Peter Caldini cited an 11% growth acceleration in the augmentation market from ASPS data.
1mo ago
16Jul
Mizuho raises Establishment Labs Hldgs target to $105
Mizuho analyst Anthony Petrone maintained an Outperform rating on Establishment Labs Hldgs (NASDAQ: ESTA) and raised the price target to $105 from $100, citing confidence in the company's growth trajectory and market position.
4mo ago
9Jul
Citigroup raises Establishment Labs Hldgs target to $92
Citigroup analyst Joanne Wuensch maintained a Neutral rating on Establishment Labs Hldgs (NASDAQ: ESTA) and raised the price target to $92 from $76.
4mo ago
29Jun
Establishment Labs appoints Taylor Harris to board of directors
Establishment Labs Holdings Inc. appoints Taylor Harris to its Board of Directors, leveraging his 25 years of healthcare and medical technology experience. Harris, former CEO of Cutera and CFO at MyoKardia, brings expertise in corporate finance and strategic acquisitions. The move aims to drive growth and innovation in the global aesthetics market.
